|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway
1 Department of Medicine, Pulmonary, Allergy and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, PA, USA
2 Department of Radiation Oncology, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA
* To whom correspondence should be addressed. E-mail: amran{at}mail.med.upenn.edu.
Elucidating the factors that inhibit the increase in airway smooth muscle (ASM) mass may be of therapeutic benefit in asthma. Here, we investigated whether interferon-gamma (IFN
), a potent inducer of growth arrest in various cell types, regulates mitogen-induced ASM cell proliferation. IFN
(1-100 U/ml) was found to markedly decrease both DNA synthesis and ASM cell number induced by the mitogens EGF and thrombin. Interestingly, IFN
had no effect on mitogen-induced activation of three major mitogenic signaling pathways, PI3-kinase, p70S6k or mitogen activated protein kinases (MAPKs). Mitogen-induced expression of cell cycle regulator cyclin D1 was increased by IFN
while no effect was observed on degradation of p27Kip1. Expression array analysis of 23 cell cycle-related genes showed that IFN
-inhibited EGF-induced increases in E2F-1 expression while induction of c-myc, cyclin D2, Egr-1 and mdm2 were unaffected. Induction of E2F-1 protein and Rb hyper-phosphorylation following mitogen stimulation was also suppressed by IFN
. In addition, IFN
decreased activation of cdk2 and expression of cyclin E, upstream signaling molecules responsible for Rb hyper-phosphorylation in the late G1 phase. IFN
also increased levels of IFI 16 protein, whose mouse homologue p202 has been associated with growth inhibition. Together, our data indicate that IFN
is an effective inhibitor of ASM cell proliferation by blocking transition from G1 to S phase by acting at two different levels, modulation of cdk2/cyclinE activation and inhibition of E2F-1 gene expression.
This article has been cited by other articles:
![]() |
M. Okamoto, K. Takeda, A. Joetham, H. Ohnishi, H. Matsuda, C. H. Swasey, B. J. Swanson, K. Yasutomo, A. Dakhama, and E. W. Gelfand Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation J. Exp. Med., May 12, 2008; 205(5): 1087 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Goncharova, D. A. Goncharov, A. Chisolm, M. S. Spaits, P. N. Lim, G. Cesarone, I. Khavin, O. Tliba, Y. Amrani, R. A. Panettieri Jr., et al. Interferon {beta} Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation Mol. Pharmacol., March 1, 2008; 73(3): 778 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Fischer, S. Zheng, R. Fan, and J. A. Voynow Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1 Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L762 - L768. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koya, K. Takeda, T. Kodama, N. Miyahara, S. Matsubara, A. Balhorn, A. Joetham, A. Dakhama, and E. W. Gelfand RANTES (CCL5) Regulates Airway Responsiveness after Repeated Allergen Challenge Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 147 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wessely Interference by interferons: Janus faces in vascular proliferative diseases Cardiovasc Res, June 1, 2005; 66(3): 433 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koga, J.-i. Suzuki, H. Kosuge, G. Haraguchi, Y. Onai, H. Futamatsu, Y. Maejima, R. Gotoh, H. Saiki, F. Tsushima, et al. Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2057 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, J. Li, A. M. Goldsmith, D. C. Newcomb, D. M. Giannola, R. G. Vosk, E. M. Eves, M. R. Rosner, J. Solway, and M. B. Hershenson Human Bronchial Smooth Muscle Cell Lines Show a Hypertrophic Phenotype Typical of Severe Asthma Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |